Apyx Medical Corporation APYX
Set alert
2.60 USD 0.00 0.00%
At close · Nov 2
2.60 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
2.53 Day range 2.80
2.25 52-week range 5.08
- YTD
- -25.71%
- 1 year
- -14.19%
- Open
- 2.58
- Prev close
- 2.60
- Mkt cap
- 109.52M
- Vol
- 116.20K
- Avg vol
- 142.47K
- EPS
- -0.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.53
- High
- 2.80
- Forward P/E
- -3.39
- Beta
- 1.21
- Short ratio
- 5.49
- Inst. own
- 40.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.41
- 200-d avg
- 1.39
- 1y target
- 2.83
1Y chart
Signals (41)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 12, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| RSI: Oversold | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| RSI: Oversold | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
Newest 20 of 41.
Analyst view
Consensus: none
Price target (mean) 2.83 +9.0% upside
Now 2.60
- Target (low)
- 2.00
- Target (mean)
- 2.83
- Target (high)
- 4.00
Ratings (0m) 5 2 buy · 3 hold · 0 sell
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.1625 | -0.18 – -0.13 | -0.18817 | +13.6% | 13.02M | -11.2% | 4 |
| Next quarter | -0.075 | -0.15 – 0.07 | -0.22 | +65.9% | 10.23M | -0.2% | 4 |
| Current year | -0.7075 | -0.72 – -0.68 | -0.53036 | -33.4% | 46.91M | -10.4% | 4 |
| Next year | -0.4025 | -0.45 – -0.33 | -0.7075 | +43.1% | 48.21M | +2.8% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 17, 2024 | BTIG | Initiated | — | Neutral |
| Sep 16, 2024 | JMP Securities | Reiterated | — | Market Perform |
| Nov 10, 2023 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 11, 2023 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 14, 2023 | Stephens & Co. | Initiated | — | Overweight |
| Jun 15, 2023 | Lake Street | Maintained | — | Buy |
| May 24, 2023 | JMP Securities | Reiterated | — | Market Perform |
| May 12, 2023 | Lake Street | Maintained | Buy | Buy |
| Aug 12, 2022 | Piper Sandler | Maintained | — | Overweight |
| Jul 19, 2022 | Lake Street | Maintained | — | Buy |
| May 20, 2022 | Lake Street | Initiated | — | Buy |
| Aug 13, 2021 | JMP Securities | Maintained | — | Market Outperform |
| May 12, 2020 | JMP Securities | Maintained | — | Market Outperform |
| Nov 12, 2019 | Piper Sandler | Maintained | — | Overweight |
| Apr 2, 2019 | JMP Securities | Maintained | Market Outperform | Market Outperform |